4-122826977-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000264498.9(FGF2):āc.202C>Gā(p.Arg68Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000107 in 1,309,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000264498.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGF2 | NM_001361665.2 | c.-198C>G | 5_prime_UTR_variant | 1/3 | ENST00000644866.2 | NP_001348594.1 | ||
FGF2 | NM_002006.6 | c.202C>G | p.Arg68Gly | missense_variant | 1/3 | NP_001997.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGF2 | ENST00000264498.9 | c.202C>G | p.Arg68Gly | missense_variant | 1/3 | 1 | ENSP00000264498 | |||
FGF2 | ENST00000644866.2 | c.-198C>G | 5_prime_UTR_variant | 1/3 | NM_001361665.2 | ENSP00000494222 | P1 | |||
FGF2 | ENST00000608478.1 | c.-198C>G | 5_prime_UTR_variant | 1/3 | 1 | ENSP00000477134 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000663 AC: 10AN: 150732Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000917 AC: 2AN: 21808Hom.: 0 AF XY: 0.0000755 AC XY: 1AN XY: 13250
GnomAD4 exome AF: 0.00000345 AC: 4AN: 1158878Hom.: 0 Cov.: 32 AF XY: 0.00000358 AC XY: 2AN XY: 558358
GnomAD4 genome AF: 0.0000663 AC: 10AN: 150836Hom.: 0 Cov.: 31 AF XY: 0.0000407 AC XY: 3AN XY: 73708
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.202C>G (p.R68G) alteration is located in exon 1 (coding exon 1) of the FGF2 gene. This alteration results from a C to G substitution at nucleotide position 202, causing the arginine (R) at amino acid position 68 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at